Web Analytics Made Easy - StatCounter

Tender for Supply Of Buprenorphine Patch 10 Mcg , Netupitant 300 Mg And Palonosetron 0 Point 5 Mg Fixed Dose , Capecitabine Dispersible 1000mg Tab , Albumin Bound Paclitaxel 100 Mg Inj , Carboplatin 150 Mg Inj , Carboplatin 450 Mg Inj , Carmustine 100 Mg Inj , Cetuximab 100mg Inj , Inj Cisplatin 50mg , Inj Eribulin 1 Mg , Fosaprepitant 150mg Inj , Fosnetupitant 235mg Plus Palonosetron 0.25mg Inj , Gemcitabine 1000 Mg Inj , Nanosomal Paclitaxel Lipid Suspension 100 Mg Inj , Oxaliplatin 100mg Inj , Inj Paclitaxel Lipid Suspension 30 Mg , Pegylated Gcsf 6 Mg Inj Peg Filgrastim , Pegylated Liposomal Doxorubicin 20mg Inj , Rasburicase 1 Point 5mg Inj , Inj Rituximab 100mg , Inj Trastuzumab 375 Mg , Patch Fentanyl 25 Mcg Transdermal , Picc 4 Fr Catheter Single Lumen , Magestrol Acetate Oral Suspension 120ml , Tab Abiraterone Acetate Dispersable 250 Mg in Panchkula - Haryana

Tender Details
Reference # :
45319194
Description :
Tenders for Supply Of Buprenorphine Patch 10 Mcg , Netupitant 300 Mg And Palonosetron 0 Point 5 Mg Fixed Dose , Capecitabine Dispersible 1000mg Tab , Albumin Bound Paclitaxel 100 Mg Inj , Carboplatin 150 Mg Inj , Carboplatin 450 Mg Inj , Carmustine 100 Mg Inj , Cetuximab 100mg Inj , Inj Cisplatin 50mg , Inj Eribulin 1 Mg , Fosaprepitant 150mg Inj , Fosnetupitant 235mg Plus Palonosetron 0.25mg Inj , Gemcitabine 1000 Mg Inj , Nanosomal Paclitaxel Lipid Suspension 100 Mg Inj , Oxaliplatin 100mg Inj , Inj Paclitaxel Lipid Suspension 30 Mg , Pegylated Gcsf 6 Mg Inj Peg Filgrastim , Pegylated Liposomal Doxorubicin 20mg Inj , Rasburicase 1 Point 5mg Inj , Inj Rituximab 100mg , Inj Trastuzumab 375 Mg , Patch Fentanyl 25 Mcg Transdermal , Picc 4 Fr Catheter Single Lumen , Magestrol Acetate Oral Suspension 120ml , Tab Abiraterone Acetate Dispersable 250 Mg
Ownership :
Sector :
Tender Values
Value :
NA
EMD :
NA
Doc. Cost :
NA
Important Dates
Due date :
08 Jun, 2026
Open date :
08 Jun, 2026
Publish date :
25 May, 2026
Location
Location :
Panchkula - Haryana ( IN )
Connect us via What's Up